Abstract Library

#4063 Analysis of the NET G3 of lungs

Introduction: There are still a lot of questions regarding NET G3 subgroup and especially with lungs origin. Neuroendocrine neoplasms account for 20% of lung primary with only 2% for well-differentiated tumors.

Conference:

Presenting Author: Evdokimova E

Authors: Evdokimova E, Markovich A, Delektorskaya V, Yemelyanova G, Kuznetsova A,

Keywords: NET, G3, SSTR, somatostatin analogues, SSA, lung,

#3315 Angiosarcoma is a rare and aggressive tumor of the Thyroid. Case Report

Introduction: Angiosarcoma(AS) of the thyroid gland is a rare(2-4% of all thyroid neoplasms) but highly malignant tumor with poor prognosis. AS showing endothelial differentiation. As most visceral ASs show epithelioid cell morphology, as well as co-expression of epithelial differentiation markers(keratins or EMA), the differential diagnosis with carcinomas is challenging. Given the importance of the correct histological diagnosis for therapy choice, this is a relevant issue

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Bondarenko E, Voronkova I, Gurevich L, Ashevscaya V, Fedorov D,

Keywords: Thyroid, Angiosarcoma, Epithelioid angiosarcoma,

#944 Pheochromocytoma and Paraganglioma in Pediatric Age

Introduction: Pheochromocytoma (PHE) and paraganglioma (PGL) are rare tumors of the adrenal medulla and extra-adrenal sympathetic chromaffin tissue. Nearly 30% of them are familiar or associated with genetic syndromes (VHL, MEN2, NF1, SDH mutation, Pacak-Zhuang). Only 20% PHE occur before 20 years of age. Incidence of pediatric PHE is 0.3:1 million.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Bajciova V

Authors: Bajciova V, Kren L, Vicha A,

Keywords: pheochromocytoma, paraganglioma, pediatric age,